FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges
Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...
vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
The company plans to resume its CATT1 Phase 3 trial for type 1 diabetes after submitting a protocol amendment.
Medscape1mon
The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy
Diabetes. 2006;55(1):1-12. Glucokinase is required for GSIR in the physiological range of 4-8 mmol/l. Glucokinase is needed for amino acid and fatty acid stimulation of insulin release.
Irish Star on MSN4mon
Two key superfoods lower blood sugar without needing insulin, experts say
Magnesium regulates an enzyme known as glucokinase, responsible for converting glucose into glucose-6-phosphate. Type 2 ...
Helsinki4y
The FINNMODY study
Glucokinase-MODY and HNF1A-MODY are the two most common subtypes of MODY. A mild subtype of MODY, glucokinase-MODY, might remain undiagnosed for decades, as the symptoms are generally mild or ...